Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.


Professor, Departments of Medicine and Surgery, David Geffen School of Medicine at UCLA; Adjunct Professor of Nursing, UCLA School of Nursing, University of California Los Angeles, Los Angeles, California

Sammy Saab, MD, MPH, is a Professor in the Departments of Medicine and Surgery at the David Geffen School of Medicine at UCLA (University of California Los Angeles) and an Adjunct Professor of Nursing at the UCLA School of Nursing. He is currently the Medical Director of the UCLA Adult Liver Transplant Program, Medical Director of the Pfleger Liver Institute, and the Chief of Transplant Hepatology. Dr. Saab is also the Head of Outcomes Research in Hepatology. He has been on the faculty at UCLA for over two decades. Dr. Saab is board certified in transplant hepatology. He has received honorary fellowships from the American Gastroenterology Association (AGAF), American College of Gastroenterology (FACG) and the American Association for the Study of Liver Diseases (FAASLD).

Dr. Saab is active on many local, national, and international committees, including the Medical Advisory Committee of the Los Angeles Chapter of the American Liver Foundation, Morbidity and Mortality Committee for the Department of Internal Medicine, and the Liver Transplant Executive Committee of the UCLA Division of Transplantation. He was on the Practice Guidelines Committee of the American Society of Transplantation (2006–2008) and the Educational Committee of the American Association for the Study of Liver Diseases (2004–2007). He has been an investigator in numerous clinical trials, a frequently invited speaker worldwide and leads a continuously annual patient education seminar.  He is has been awarded one of the “Best Doctors in America”, received the Distinguished Achievement Award from his Division of Digestive Diseases, and was awarded an honorary fellowship degree from the American Gastroenterological Association and the American Association for the Study of Liver Disease.

Dr. Saab has published almost 200 peer-reviewed articles. He has also authored many book chapters, editorials, abstracts, and poster presentations. Dr. Saab is on the editorial board of over a dozen journals.


Dr. Saab reports the following:
  • Speakers Bureau: AbbVie, Eisai, Exelixis, Gilead, Intercept, Salix, Takeda, Mallinckrodt
  • Consultant: Gilead, Mallinckrodt, Eisai, Exelixis